ID: ALA4591086

Max Phase: Preclinical

Molecular Formula: C26H37F2N9O4S

Molecular Weight: 609.70

Molecule Type: Unknown

Representations

Canonical SMILES:  COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCC(N(C)S(=O)(=O)CCN(C)C)CC2)n1

Standard InChI:  InChI=1S/C26H37F2N9O4S/c1-33(2)14-17-42(38,39)34(3)18-8-10-35(11-9-18)24-30-25(36-12-15-41-16-13-36)32-26(31-24)37-19-6-5-7-20(40-4)21(19)29-23(37)22(27)28/h5-7,18,22H,8-17H2,1-4H3

Standard InChI Key:  ZFZBJUZHFVUOKP-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 609.70

Molecular Weight (Monoisotopic): 609.2657

AlogP: 1.79

#Rotatable Bonds: 10

Polar Surface Area: 122.05

Molecular Species: NEUTRAL

HBA: 12

HBD: 0

#RO5 Violations: 2

HBA (Lipinski): 13

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 2

CX Acidic pKa:

CX Basic pKa: 7.22

CX LogP: 2.36

CX LogD: 2.13

Aromatic Rings: 3

Heavy Atoms: 42

QED Weighted: 0.33

Np Likeness Score: -1.24

References

1. Giddens AC, Gamage SA, Kendall JD, Lee WJ, Baguley BC, Buchanan CM, Jamieson SMF, Dickson JMJ, Shepherd PR, Denny WA, Rewcastle GW..  (2019)  Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474.,  27  (8): [PMID:30850264] [10.1016/j.bmc.2019.02.050]

Source

Source(1):

• Scientific Literature